Enzymotec announces big R&D investment
Israeli ingredients manufacturer Enzymotec has unveiled a US$3.5m R&D budget for 2007 - a significantly higher investment than in previous years which is mostly earmarked for funding clinical trials.
Israeli ingredients manufacturer Enzymotec has unveiled a US$3.5m R&D budget for 2007 - a significantly higher investment than in previous years which is mostly earmarked for funding clinical trials.
Weekly Comment
There's no way but out for heart-damaging trans fatty acids, and procrastinators in the food industry will achieve nothing by delaying reformulation other than lagging behind in the game as the rest of the world waves goodbye.
Scientists from the University of Illinois in Chicago have reported for the first time just how black cohosh may alleviate hot flushes in menopausal women - information previously lacking about the herb.
As the regulatory landscape for supplements in Asia is shifting towards greater harmonisation, officials from around the globe can pool knowledge and learn from each others' systems, according to IADSA.
A high-dose vitamin K supplement reduced calcium precipitates associated with hardening of the arteries by 37 per cent in rats, scientists from The Netherlands have reported.
Not all açai is ethically equal, according to one distributor, but managed the right way the industry for this Amazonian superfruit could protect the endangered rainforest and bring about positive social development in the region.
The high calorie, low fibre dietary pattern associated with the Western diet are associated with an increased risk of colorectal cancer, says new research from France.